Project description:Expression analysis (RNA-seq) and RPPA data (see publication) of head and neck cancer patient-derived xenographs (PDXs) revealed Sox-2 and Cav-1 expression to be biomarker determinants of head and neck cancer patient tumor response to cetuximab (EGFR inhibitor) treatment.
2021-10-12 | GSE183881 | GEO
Project description:Cancer hotspot mutation sequencing of patient derived xenografts of head and neck cancer
